|
ANKRD12 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.610400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.859600E-01 |
| Normal-vs-Stage2 |
4.941000E-01 |
| Normal-vs-Stage3 |
7.678500E-03 |
| Normal-vs-Stage4 |
1.137770E-02 |
| Stage1-vs-Stage2 |
5.695200E-01 |
| Stage1-vs-Stage3 |
8.841800E-04 |
| Stage1-vs-Stage4 |
2.519700E-03 |
| Stage2-vs-Stage3 |
4.641900E-02 |
| Stage2-vs-Stage4 |
4.660000E-02 |
| Stage3-vs-Stage4 |
9.218200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.472600E-01 |
| Normal-vs-AfricanAmerican |
1.229000E-01 |
| Normal-vs-Asian |
9.843600E-01 |
| Caucasian-vs-AfricanAmerican |
2.708600E-01 |
| Caucasian-vs-Asian |
8.416800E-01 |
| AfricanAmerican-vs-Asian |
5.139000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.494030E-01 |
| Normal-vs-Female |
8.761400E-01 |
| Male-vs-Female |
9.835600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.969700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.429600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.076100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.915590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.063300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.390800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.092600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.442400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.202840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.210000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.918470E-02 |
| Normal-vs-Grade 2 |
2.603200E-01 |
| Normal-vs-Grade 3 |
1.854150E-02 |
| Normal-vs-Grade 4 |
1.647320E-04 |
| Grade 1-vs-Grade 2 |
6.564400E-02 |
| Grade 1-vs-Grade 3 |
3.99470000000957E-06 |
| Grade 1-vs-Grade 4 |
6.17560000026884E-07 |
| Grade 2-vs-Grade 3 |
1.767040E-04 |
| Grade 2-vs-Grade 4 |
9.69659999960903E-07 |
| Grade 3-vs-Grade 4 |
4.302000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.918300E-02 |
| Normal-vs-ccB subtype |
1.898540E-03 |
| ccA subtype-vs-ccB subtype |
8.35840000545929E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.506400E-01 |
| Normal-vs-N1 |
1.004630E-01 |
| N0-vs-N1 |
3.697800E-01 |
|
|
